Exam 2 Flashcards
Interphase
Nucleus is visible and cell function occur
G1, S, G2
G1
btw cytokinesis and S phase
Chr are single
new organelles are formed
cell grows in size
Restriction point
G1-S transition
commitment to DNA replication and division
Can put cell in G0
G0
Resting phase. Quiescent or Senescent
Quiescent
Reversible. lack of cell growth signals
growth inhibitory signals (TGFBeta)
DNA dmg detected by p53
Senescent
Irreversible. telemoere shortening
still can function. alt to apop
S phase
DNA replicates
Sister chromatid remain together
G2
Prepares for mitosis
M phase
Mitosis
Prophase, metaphase, anaphase, telophase
G1/S
DNA damage checkpoint: S phase blocked
G2/M
checks if replication is complete
SAC
Anaphase blocked if chromatds are not properly assembled on mitotic spindle
CDKs
Cyclin dependent protiens
Ser/Thr
activated by binding to cyclin
CK4/6
Cyclin D - G1 pase
CDK2
Cyclin E - G1/S
Cyclin A - S
CDK1
Cyclin A - S/G2
Cyclin B - M
Inhibitors for CDK-Cyclin Activity
D-CDK4/6 = p16,p15,p18,p19
Cyclin E,A,B = p21,p27,p21
TGF beta
Induces p15 and p21
p53
inhibits through p21
pRb
inhibits cell cycle at R pt - binds to E2F
extensive phosphorylation of RB allows cell cycle progression
Cyclin D-CDK and Cyclin E-CDK control phosphorylation
Mitosis promoting Factor (MPF)
G2-M transition
Cyclin B combines with CDK1 = MPF
reaches critical lvl at end of G2 and counts to peak through M
Activates Anaphase promoting complex (AC/C)
SAC
Spindle assemble checkpoint
INhibits APC/C until CHR aligned on metaphase plate and checks kinetochores
4 modes of cell singaling
Endocrine = insulin
Paracrine = GF
Synpatic = AcH
Contact Dependent = Notch
Growth Factors
molecules released by cell that signal other cells
promote differentiation and maturation
Cytokines
proteins involved in immune response
Hormones
proteins, steriods, fatty acid derivatives produced by endocrine glands (long range)
Enzyme - coupled receptors
act as enzymes/ assosiate with enzymes in the cell
Control cell growth, proliferation, differentiation, survival
Ligands
Receptor - Tyrosine kinases (RTKs)
enzyme coupled
3 domains = Extracellular, Transmembrane, Cytoplasmic
Activates Ras, PI-3K
Dimer
2 receptor molecules associate
PI-3K signlaing
promotes cell survival
PI-3K works
1) PI3K binds to RTK and phosphorylates
2) PI-33k Phosporylates PIP2 which makes PIP3
3) PIPs recruit Akt and PDK1
4) PDK1 and mTor phosphorylate Akt
5) Akt released into cytosol where activates other intracellular proteins
6) Akt activates Bad, pro-apoptotic protein
7) Bcl2 released and promotes cell survival
PTEN
dephosphorylates PIP3
Tumor Supressor
men with prostate cancer have lost this
Mechanisms for targeting growth factor receptors
Downstream pathways
anti-ligand
Anti receptor
Receptor inhibitor
Anti ligand
use antibodies to target ligand
Anti receptor
use antibodies target the RTK
Receptor inhibitor
molecule inhibitor of RTK to reduce activity
HER2
gene encoding for RTK
overexpressed in breast cancer
Herceptin (traztuzibmab)
HER2 therapy
blocks downstam HER2
Flags HER2+ cells for destruction
Signal diversity
receptors activate multiple intracellular pathways
multiple effects of one signal receptor
Cross talk
pathways regulated by other pathways
Redundancy
pathways activated by more than one receptor
Diff signals but similar effects
Signal amplification
multiple steps in pathway allows for signal to be amplified
small amt of ligand = big effects
Apoptosis
programmed cell death/cell suicide Orderly cells into parcels plasma memb remains inact recycle parts Reponse to genomic dmg anoxia signaling imbalances
Atrophy
too much cell death
Parkinson’s and alzheimer’s
Hyperplasia
Not enough cell death
Cancer
Necrosis
response to toxxic chemical/physical injury
messy
leaks cellular components
causes immune response
Morphological changes in apoptosis
Pyknosis
memb blebbing
rounding of cell
reduction of cell vol
Pyknosis
chromatin condensation
nucleus collapsed into dense structure due to chromatin condensation
Anoxia
oxygen deprivation
Blebs
patches of plasma memb extrude
Apoptotic bodies
cell broken up into small fragments
Memb bound
Phophatidylserine
membrane protein flips out from inner layers, signals macrophage
3 pathways lead to apoptosis
Extrinsic - death ligand
Intrinsic - radiation,toxins
Perforin/granzyme - cytotoxic t cells
Caspasses
family of cysteine aspartyl-specififc protease enzymes that cleave proteins after an aspartic acid
Initiator
initiate apaoptosis by cleaving other caspases
Executioner
cleave multiple structural and repair proteins
Bcl2 Family protiens
Pro apoptotic
Pro survival
fate of cell determined by these
Pro-Apoptotic
promote release of cytochrome c from mitochondria
Pro-Survival
block release of cytochrome c from mitochondria
Apoptosome
complex of cytochrom c and Apaf-1
Activates caspase-3
Cancer reciprocal translocations
Between chromosomes 14 and 18
causes BCL-2 to come under control of constitutive promotor
Treatment of Apaptosis in cancer
Bcl-2 inhibitors
p53 activation
IAP inhibitors
Potential threats to geonme stability
Errors by DNA pol Errors by MMR enzy Double strand breaks Incorporation of chemically altered nucleotides Attack from mutatgens Defects in DNA repair
Mismatch repair enzymes
monitor recently synthesized DNA to detect errors
Satellite
highly repeated sequences 100+ nuc
Microsatellites
highly repeated sequences that are short
Microsatellite Instability
expansion or shrinkage in regions of repeated nucleotides
Replication fork
Vulnerable to breakages
Considered a DB strand break even when one strand breaks only
Exogenous Mutagens
Reactive oxygen species
Superoxide ions
Hyrdrogen peroxise
radicals
Depurination
spontaneous loss of purine base
Depyrimidination
spontanrous loss of pyrimidine
Deammination
Loss of amine group protrudine from guanine adenine and cytosine
Transition Mutation
one pyrimidine replaces another pyrimidine
Transversion
putine replacing pyrimidine vice versa
UV irradiation
produces cross links between adjacent pyrimidine bases
Alkylating agents
add alkyl group through covalent attachment
Used as chemotherapy
destabilizes bonds
DNA adducts
Chemical entity formed after reaction of carcinogen with DNA base
Aflatoxin B1 (AFB1)
Exogenous carcinogen produced by molds
Heterocyclic Amines
Arise from cooking foods at high temperatures
Defenses against mutagens
Physical shield
Enzymes including superoxide dismutase
repair enzymes
Free radical scavengers (vitamin C)
Repair Enzymes fix altered DNA
Dealkylating enzyme
Base excision repair
Nucleotide excision repair
Error prone repair
occurs when DNA replication fork encounters a still unrepaired DNA lesion
dsDNA repair
Homologydirected repair
Nonhomologous end joining
Caretakers
maintenance of genomic integrity
Gate-keepers
Tumor Supressors
BRCA
germline mutations that increase risk of cancer
Chromosomal trnaslocations
Chromatid breaks
Triradial chromosomes
Chromosome Instability
Changes in chromosome number
Merotelic Attachment
kinetochore attached to two spindle poles
Centrosomes
organize microtubules in mitotic spindle commonly amplified in cancer cells
Targeting these can kill cancer cells
Tumor Progression
process by which normal cells evolve with increasingly neoplastic phenotypes
Multistep tumorigenesis
concept that carcinogenesis takes place in discrete stepes
Andeonmas (polyps)
precursors to carcinoma
Familial adenomatous polposis (FAP)
if have = colon carcinoma
Inherit mutation in TS APC on chr 5
P and Q arms
Submetacentric
Metcentric
Telocentric
Acrocentric
Field Cancerization
Multiple apperently independent tumor arise in same organ
Sep. by normal epithelium
Poised for cancer prog
Tumorigenesis
Succession of clonal expansions
Darwininan Evolution
Individual cells compete with one another
random mutations create variation
FAvor proliferation and survival
Stochastic/Clonal Evolution model
Accumilation of mutations enhances resistance and fitness of tumor cells
All cells have similar chance in becoming a tumor
Intra-Tumor Heterogeneity
Tumor genomes become increasingly unstable
Rate of mutation soars with each gen
Cancer Stem Cell Model
Hierarchical Model
Some types of cancer have subpopulation of stem cells in tumor
Stem cells are not differentiated and are capable of self renewal
Stem cells can induce tumor similar to themselves
5 Pathway alterations
Human cells highly resistant to transformation
Pathway Ras pRb p53 Telomeres PP2A
Driver mutations
give cell growth advantage
Passenger mutations
other mutations already in the cell
Skin carcinoma in mice
Initiator = stable long live mark Promoter = repeat exposures cause inc prolif and is dose depenent
Tumor Latency
Time btw initiation and development of detectable tumor
Tumor promoters
Chronic inflamation
Mitogenic agents
Complete Carcinogens
Act as initiator and promoter